Gene Query: MICU2

Dataset Description Geneva Score
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 48.89
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 24.86
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 24.86
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 19.65
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 19.03
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 17.55
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.69
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 15.7
Uridylation by TUT4 and TUT7 marks mRNA for degradation 14.76
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 13.41
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 13.4
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 13.24
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 13.04
HNRNPM-regulated splicing dependencies in prostate cancer 13.02
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 13.02
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 12.98
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 12.74
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 12.65
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 12.43
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.95
A prostate cancer chromatin interaction map 11.89
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 11.73
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 10.99
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 10.89
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.75
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 10.74
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 10.4
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 10.25
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 10.14
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 10.14
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.89
Patient-derived luminal breast cancer xenografts with progestins 9.89
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 9.84
Effect of CHKA knockdown on C4-2 cell transcriptome 9.55
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 9.32
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 9.29
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.24
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 9.2
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 8.83
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 8.67
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.56
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 8.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 8.47
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 8.43
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.42
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.42
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.97
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.89
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.62
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 7.58
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 7.55
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 7.55
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.52
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 7.47
Effect of mitochondria deficiency on senescence-associated gene expression 7.45
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 7.43
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 7.43
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.42
RNA-Seq from early time points in the kidney differentiation protocol 7.29
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 7.14
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 7.08
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.05
Tracking distinct RNA populations using efficient and reversible covalent chemistry 7.03
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.99
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.99
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.95
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.93
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.67
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.65
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 6.62
HNRNPL and its RNA Targets in Prostate Cancer 6.62
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 6.5
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.35
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 6.33
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 6.33
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.32
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 6.28
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 6.28
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 6.24
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 6.24
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.1
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.07
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.07
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 6.04
BET bromodomain inhibition 6.04
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.97
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 5.91
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.84
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.79
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.77
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 5.68
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 5.67
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.64
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.57
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.54
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.51
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 5.51
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 5.51
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.43
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 5.43
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.4
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.34
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 5.33
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.29
Human cell line and subcutaneous tumor 5.27
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 5.24
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.23
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.18
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.16
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 5.14
RNA-seq analyisis of PUM2 knockout cells 5.04
Effect of disulfiram treatment on pediatric high grade glioma 4.96
RNA-Seq with and without RNase treatment in PCa cell lines 4.96
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 4.95
Effect of PBK knockdown on C4-2 cell transcriptome 4.95
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 4.95
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 4.95
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.93
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 4.92
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 4.92
Transcriptome of human white and brown adipose tissue biopsies 4.91
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.91
Interaction between mitoNEET and NAF-1 in cancer cells 4.91
RNAseq Study in CC-671 Treated Cal-51 Cells 4.9
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.89
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.89
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.88
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.88
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.86
RNAseq of T-ALL upon long non coding rna purturbation 4.86
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.86
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.86
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.85
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.8
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 4.79
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.77
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.75
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.75
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.73
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.73
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.7
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.69
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.69
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 4.63
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.59
Regulation of protein translation during mitosis 4.59
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 4.58
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 4.54
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 4.54
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.46
Gene expression profiling of leukemia cells following asparagine depletion 4.46
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 4.45
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.44
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.4
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.38
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.38
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 4.35
Regulation of highly expressed hCINAP on translatome 4.34
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.33
BAF controls genome accessibility 4.33
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 4.31
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.3
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 4.3
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 4.28
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.27
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.25
Global Mapping of Human RNA-RNA Interactions 4.21
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.21
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.19
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.18
Ribosomal footprinting of MDA-Parental and MDA-LM2 4.17
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 4.16
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 4.13
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.12
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.11
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.09
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.09
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 4.08
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.07
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 4.06
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.03
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.03
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 4.02
Transciptomic profiling of human fetal lung samples 4.02
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.02
miRNAs affected by antagomiR-17 treatment 4.0
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.97
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 3.96
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 3.96
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.92
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.92
RNA-seq of YB5 cells treated with Proscillaridin A 3.87
Single-cell analysis of adult human ovary using 10X genomics 3.86
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.84
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.84
Effect of from Human Umbilical Vein Endothelial Cells 3.79
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.77
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.77
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 3.73
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 3.73
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.73
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.71
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.65
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.63
GATA3-mediated chromatin reprogramming in breast cancer cells 3.63
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.62
Single-cell analysis of human kidney organoids 3.61
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.6
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.59
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.57
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.56
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 3.55
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.53
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.52
O-glcnAc reprograms cellular energetics 3.52
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 3.49
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.48
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.48
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 3.48
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.44
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 3.42
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 3.4
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 3.4
Transcriptome-wide modulation of splicing by the exon junction complex 3.39
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.35
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.35
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 3.33
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 3.33
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.3
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.29
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.26
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.26
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 3.26
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 3.26
The contribution of Alu exons to the human proteome 3.24
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 3.23
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.15
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.06
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.05
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.04
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.01
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.01
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.0
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.0
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.99
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 2.98
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.95
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.94
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 2.91
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.91
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.89
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.86
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.86
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 2.85
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 2.85
Regulation of hypoxia-inducible factor activity by ZMYND8 2.83
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.83
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.83
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 2.82
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.8
MCF-7 as a model for functional analysis of breast cancer risk variants 2.8
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.79
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.78
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.77
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.77
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.77
The Genetic Landscape of Diamond-Blackfan Anemia 2.73
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.71
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.71
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.7
The transcriptome effect of overexpressing EZH2 in MCF7 2.68
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.65
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.65
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.63
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.61
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.59
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 2.58
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 2.57
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.57
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.56
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.53
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.53
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.52
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.52
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 2.51
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.48
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.48
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 2.45
Tyrosine Kinase Inhibitor Cardiotoxicity 2.45
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.43
Ribosome profiling upon inhibition of eIF4A 2.42
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.41
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.41
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.41
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.39
Genome-wide analysis of the Integrator complex (HTS) 2.39
Genome-wide analysis of the Integrator complex 2.39
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.35
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 2.32
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.29
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.28
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.27
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.26
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.23
Androgen Receptor-regulated genes in prostate cancer cells 2.23
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.23
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.2
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.2
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.2
scRNASeq analysis of cycling cardiomyocytes 2.19
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 2.19
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.18
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.18
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.17
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 2.17
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.16
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.16
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 2.16
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.15
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.15
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.14
Lysine benzoylation is a novel histone mark [RNA-seq] 2.13
Lysine benzoylation is a novel histone mark 2.13
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.12
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.12
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.12
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.11
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.05
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.05
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.03
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.03
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.03
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.02
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.01
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.01
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.97
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.97
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.97
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.95
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 1.95
Discovering human diabetes-risk gene function with genetics and physiological assays 1.93
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.93
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.9
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.9
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.88
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.87
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.87
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 1.87
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.85
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.83
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.83
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.83
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.82
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.78
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.77
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.77
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.77
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.77
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.76
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.74
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.73
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.73
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.71
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.71
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.69
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.64
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.63
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.62
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.62
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.62
The transcriptome and chromatin accessbility landscape of mammalian germline 1.61
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.56
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.53
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.5
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.48
Dilated cardiomyopathy vs Myocarditis 1.45
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.44
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.42
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.42
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.42
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.4
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.38
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.37
RNA-Seq of PRMT1 overexpression ECA109 cells 1.37
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.36
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.36
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.35
Role of COP1 on MAP kinase transcriptional output in melanoma 1.3
LIN28A Over-expression RNAseq 1.26
siRNA-mediated knockdown 1.26
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.25
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.23
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 1.23
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 1.22
Functional significance of the HIV-1 Tat signature amino acid residues 1.22
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.18
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.18
Global transcriptome analysis of HAP1 cells 1.14
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.12
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.12
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.11
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.06
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.04
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.03
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.03
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.02
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.01
Modeling Human Cancer-induced Cachexia (Human) 1.01
FBXW7 modulates stress response by post-translational modification of HSF1 0.96
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.96
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.96
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.93
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.91
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.87
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.86
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.83
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.83
HEK293 TFAM Knockout Expression Study 0.82
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.81
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.8
Human Treg IFNg/IL-10 subpopulations 0.79
HBEC-shp53-PCHD7 0.78
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.78
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.78
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.77
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.77
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.76
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.75
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.73
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.72
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.7
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.68
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.67
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.67
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.65
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.64
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.63
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.59
Human Treg IL-12 stimulation 0.57
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.56
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.56
RNAseq of cell lines with knocked in ESR1 mutations 0.55
RNA-seq of cells with TET1 knockout 0.55
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.55
FOXP1 orchestration of ASD-relevant signaling pathways. 0.54
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.52
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.52
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.51
Expression profiling of MCF-7 cells with treatment of TCDD 0.48
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.48
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.45
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.45
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.43
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.4
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.4
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.39
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.38
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.38
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.35
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.35
Iron response of HepG2 cells 0.35
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.34
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.34
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.32
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.32
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.31
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.3
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.3
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.28
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.27
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.25
p63 controls the enhancer landscape during keratinocyte differentiation 0.24
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.24
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.23
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.21
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.21
Transcriptional landscape changes during human embryonic stem cell derivation 0.2
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.2
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.19
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.19
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.19
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.19
Impact on erythroid progenitor type on erythroid differntiation 0.14
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.13
Role of FGFR1 in neuronal devlopment 0.11
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.11
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.1
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.1
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.09
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.09
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.09
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.06
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.06
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.04
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.03
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.03
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.02
PTHrP overexpression in MCF7 cells 0.02
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation